Found: 97
Select item for more details and to access through your institution.
RAF265, a dual BRAF and VEGFR2 inhibitor, prevents osteoclast formation and resorption. Therapeutic implications.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 1, p. 200, doi. 10.1007/s10637-012-9845-3
- By:
- Publication type:
- Article
Peptidylarginine deiminase 3 modulates response to neratinib in HER2 positive breast cancer.
- Published in:
- Oncogenesis, 2024, v. 13, n. 1, p. 1, doi. 10.1038/s41389-024-00531-4
- By:
- Publication type:
- Article
Transcriptomic Mapping of Non-Small Cell Lung Cancer K-RAS p.G12C Mutated Tumors: Identification of Surfaceome Targets and Immunologic Correlates.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2021.786069
- By:
- Publication type:
- Article
Bortezomib is an efficient agent in plasma cell leukemias.
- Published in:
- International Journal of Cancer, 2005, v. 114, n. 4, p. 665, doi. 10.1002/ijc.20793
- By:
- Publication type:
- Article
Ocoxin Oral Solution Triggers DNA Damage and Cell Death in Ovarian Cancer.
- Published in:
- Nutrients, 2024, v. 16, n. 15, p. 2416, doi. 10.3390/nu16152416
- By:
- Publication type:
- Article
Antitumoral Properties of the Nutritional Supplement Ocoxin Oral Solution: A Comprehensive Review.
- Published in:
- Nutrients, 2020, v. 12, n. 9, p. 2661, doi. 10.3390/nu12092661
- By:
- Publication type:
- Article
Central Role of Cell Cycle Regulation in the Antitumoral Action of Ocoxin.
- Published in:
- Nutrients, 2019, v. 11, n. 5, p. 2, doi. 10.3390/nu11051068
- By:
- Publication type:
- Article
Evaluation of transcriptionally regulated genes identifies NCOR1 in hormone receptor negative breast tumors and lung adenocarcinomas as a potential tumor suppressor gene.
- Published in:
- PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0207776
- By:
- Publication type:
- Article
Integrin ανβ6 Protein Expression and Prognosis in Solid Tumors: A Meta-Analysis.
- Published in:
- Molecular Diagnosis & Therapy, 2020, v. 24, n. 2, p. 143, doi. 10.1007/s40291-020-00450-1
- By:
- Publication type:
- Article
Impact of Availability of Companion Diagnostics on the Clinical Development of Anticancer Drugs.
- Published in:
- Molecular Diagnosis & Therapy, 2017, v. 21, n. 3, p. 337, doi. 10.1007/s40291-017-0267-y
- By:
- Publication type:
- Article
Multiple mechanisms contribute to acquired TRAIL resistance in multiple myeloma.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03466-3
- By:
- Publication type:
- Article
Mapping Bromodomains in breast cancer and association with clinical outcome.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-41934-3
- By:
- Publication type:
- Article
Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.605633
- By:
- Publication type:
- Article
In silico transcriptomic mapping of integrins and immune activation in Basal-like and HER2+ breast cancer.
- Published in:
- Cellular Oncology (2211-3428), 2021, v. 44, n. 3, p. 569, doi. 10.1007/s13402-020-00583-9
- By:
- Publication type:
- Article
ERK5 Interacts with Mitochondrial Glutaminase and Regulates Its Expression.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3273, doi. 10.3390/ijms25063273
- By:
- Publication type:
- Article
Antitumoral Activity of a CDK9 PROTAC Compound in HER2-Positive Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5476, doi. 10.3390/ijms23105476
- By:
- Publication type:
- Article
Transcriptomic Profiles of CD47 in Breast Tumors Predict Outcome and Are Associated with Immune Activation.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 8, p. 3836, doi. 10.3390/ijms22083836
- By:
- Publication type:
- Article
Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 23, p. 9034, doi. 10.3390/ijms21239034
- By:
- Publication type:
- Article
Antibody Conjugation of Nanoparticles as Therapeutics for Breast Cancer Treatment.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 17, p. 6018, doi. 10.3390/ijms21176018
- By:
- Publication type:
- Article
HER3 Overexpression and Survival in Solid Tumors: A Meta-analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 4, p. 266, doi. 10.1093/jnci/djs501
- By:
- Publication type:
- Article
Effect of Multikinase Inhibitors on Caspase-Independent Cell Death and DNA Damage in HER2-Overexpressing Breast Cancer Cells.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 18, p. 1432, doi. 10.1093/jnci/djq315
- By:
- Publication type:
- Article
Antitumoral effect of Ocoxin, a natural compound-containing nutritional supplement, in small cell lung cancer.
- Published in:
- International Journal of Oncology, 2018, v. 53, n. 1, p. 113, doi. 10.3892/ijo.2018.4373
- By:
- Publication type:
- Article
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 5, p. 1, doi. 10.15252/emmm.201911498
- By:
- Publication type:
- Article
Prognostic value of the immune target CEACAM6 in cancer: a meta-analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359211072621
- By:
- Publication type:
- Article
HER3 in cancer: from the bench to the bedside.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02515-x
- By:
- Publication type:
- Article
Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02330-4
- By:
- Publication type:
- Article
Biological insights into effective and antagonistic combinations of targeted agents with chemotherapy in solid tumors.
- Published in:
- Cancer & Metastasis Reviews, 2014, v. 33, n. 1, p. 295, doi. 10.1007/s10555-013-9451-7
- By:
- Publication type:
- Article
Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 3, p. 693, doi. 10.1007/s10549-018-05100-z
- By:
- Publication type:
- Article
Epigenetic modulation of FOXM1-gene interacting network by BET inhibitors in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 172, n. 3, p. 725, doi. 10.1007/s10549-018-4965-x
- By:
- Publication type:
- Article
Transcriptomic analyses identify association between mitotic kinases, PDZ-binding kinase and BUB1, and clinical outcome in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 1, p. 1, doi. 10.1007/s10549-016-3720-4
- By:
- Publication type:
- Article
The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation.
- Published in:
- Nephrology Dialysis Transplantation, 2008, v. 23, n. 11, p. 3403, doi. 10.1093/ndt/gfn333
- By:
- Publication type:
- Article
Clinical, genetic and pharmacological data support targeting the MEK5/ERK5 module in lung cancer.
- Published in:
- NPJ Precision Oncology, 2021, v. 5, n. 1, p. 1, doi. 10.1038/s41698-021-00218-8
- By:
- Publication type:
- Article
Effect of p95HER2/611CTF on the Response toTrastuzumab and Chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 11, p. 1, doi. 10.1093/jnci/dju291
- By:
- Publication type:
- Article
Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Antitumoral effect of Ocoxin in hepatocellular carcinoma.
- Published in:
- Oncology Letters, 2017, v. 14, n. 2, p. 1950, doi. 10.3892/ol.2017.6440
- By:
- Publication type:
- Article
The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 4, p. 1, doi. 10.1002/ctm2.1217
- By:
- Publication type:
- Article
The activation of the Sox2 RR2 pluripotency transcriptional reporter in human breast cancer cell lines is dynamic and labels cells with higher tumorigenic potential.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00308
- By:
- Publication type:
- Article
HER2 heterogeneity and resistance to anti-HER2 antibody-drug conjugates.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02098-z
- By:
- Publication type:
- Article
Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-02051-0
- By:
- Publication type:
- Article
MZ1 co-operates with trastuzumab in HER2 positive breast cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01907-9
- By:
- Publication type:
- Article
Proteolysis targeting chimeras (PROTACs) in cancer therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01672-1
- By:
- Publication type:
- Article
Overexpression of RasN17 Fails to Neutralize Endogenous Ras in MCF7 Breast Cancer Cells.
- Published in:
- Journal of Biochemistry, 2005, v. 137, n. 6, p. 731, doi. 10.1093/jb/mvi092
- By:
- Publication type:
- Article
The immunoglobulin‐like domain of neuregulins potentiates ErbB3/HER3 activation and cellular proliferation.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 7, p. 1061, doi. 10.1002/1878-0261.12310
- By:
- Publication type:
- Article
Regulation of the prometastatic neuregulin- MMP13 axis by SRC family kinases: therapeutic implications.
- Published in:
- Molecular Oncology, 2017, v. 11, n. 12, p. 1788, doi. 10.1002/1878-0261.12145
- By:
- Publication type:
- Article
The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 4, p. 470, doi. 10.1111/j.1365-2141.2008.07049.x
- By:
- Publication type:
- Article
Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 5, p. 858, doi. 10.1046/j.1365-2141.2003.04706.x
- By:
- Publication type:
- Article
Functional transcriptomic annotation and protein–protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 5, p. 1896, doi. 10.1002/cam4.1406
- By:
- Publication type:
- Article
Activation of the PI3K/mTOR/AKT Pathway and Survival in Solid Tumors: Systematic Review and Meta-Analysis.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0095219
- By:
- Publication type:
- Article
Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0034914
- By:
- Publication type:
- Article